New Drug Causes 20 Percent Weigh Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
Differences emerged as to which participants were more likely to cut back on drinking after starting medication. For example, ...
The proposed rule could give millions of Americans access to the new drugs; it would also put pressure on the federal budget.
Martin Makary, President-elect Trump’s pick to run the U.S. Food and Drug Administration ... in the middle of a fight ...
"Influencers on social media platforms like TikTok and Instagram only show the good things that happen and say 'look how good ...
According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback